Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

230 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn's disease.
Yoshimura N, Yokoyama Y, Matsuoka K, Takahashi H, Iwakiri R, Yamamoto T, Nakagawa T, Fukuchi T, Motoya S, Kunisaki R, Kato S, Hirai F, Ishiguro Y, Tanida S, Hiraoka S, Mitsuyama K, Ishihara S, Tanaka S, Otaka M, Osada T, Kagaya T, Suzuki Y, Nakase H, Hanai H, Watanabe K, Kashiwagi N, Hibi T. Yoshimura N, et al. Among authors: tanida s. BMC Gastroenterol. 2015 Nov 19;15:163. doi: 10.1186/s12876-015-0390-3. BMC Gastroenterol. 2015. PMID: 26585569 Free PMC article. Clinical Trial.
Randomised clinical trial: a multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease.
Kinoshita Y, Ashida K, Hongo M; Japan Rabeprazole Study Group for NERD. Kinoshita Y, et al. Aliment Pharmacol Ther. 2011 Jan;33(2):213-24. doi: 10.1111/j.1365-2036.2010.04508.x. Epub 2010 Nov 14. Aliment Pharmacol Ther. 2011. PMID: 21083596 Free article. Clinical Trial.
Acid-suppressive effect of rabeprazole 5 mg and 10 mg once daily by 24-hour esophageal pH monitoring in patients with non-erosive reflux disease in Japan: a multicenter, randomized, parallel-group, double-blind pharmacodynamic study.
Ashida K, Kinoshita Y, Hongo M; Japan Rabeprazole Study Group for NERD. Ashida K, et al. Dig Dis Sci. 2011 Aug;56(8):2333-42. doi: 10.1007/s10620-011-1583-4. Epub 2011 Feb 8. Dig Dis Sci. 2011. PMID: 21302138 Clinical Trial.
Combination therapy with adalimumab plus intensive granulocyte and monocyte adsorptive apheresis induced clinical remission in a Crohn's disease patient with the loss of response to scheduled adalimumab maintenance therapy: a case report.
Ozeki K, Tanida S, Mizushima T, Mizoshita T, Tsukamoto H, Hirata Y, Murakami K, Shimura T, Kataoka H, Kamiya T, Joh T. Ozeki K, et al. Among authors: tanida s. Intern Med. 2012;51(6):595-9. doi: 10.2169/internalmedicine.51.6801. Epub 2012 Mar 15. Intern Med. 2012. PMID: 22449667 Free article.
Adalimumab for the treatment of Japanese patients with intestinal Behçet's disease.
Tanida S, Inoue N, Kobayashi K, Naganuma M, Hirai F, Iizuka B, Watanabe K, Mitsuyama K, Inoue T, Ishigatsubo Y, Suzuki Y, Nagahori M, Motoya S, Nakamura S, Arora V, Robinson AM, Thakkar RB, Hibi T. Tanida S, et al. Clin Gastroenterol Hepatol. 2015 May;13(5):940-8.e3. doi: 10.1016/j.cgh.2014.08.042. Epub 2014 Sep 19. Clin Gastroenterol Hepatol. 2015. PMID: 25245624 Free article. Clinical Trial.
Managing refractory Crohn's disease: challenges and solutions.
Tanida S, Ozeki K, Mizoshita T, Tsukamoto H, Katano T, Kataoka H, Kamiya T, Joh T. Tanida S, et al. Clin Exp Gastroenterol. 2015 Apr 10;8:131-40. doi: 10.2147/CEG.S61868. eCollection 2015. Clin Exp Gastroenterol. 2015. PMID: 25914555 Free PMC article. Review.
230 results